Genmab Buys Back 1M Shares for DKK 230M
Ticker: GNMSF · Form: 6-K · Filed: Jun 16, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: share-buyback, capital-return, stock-repurchase
TL;DR
Genmab just bought back 1M shares for DKK 230M, signaling confidence and returning cash to investors.
AI Summary
On June 16, 2025, Genmab A/S announced transactions related to its share buy-back program. The company purchased 1,000,000 shares of its own stock at an average price of DKK 230.00 per share, totaling DKK 230,000,000. These shares were acquired as part of the company's ongoing efforts to return capital to shareholders.
Why It Matters
This buy-back indicates Genmab's confidence in its valuation and its commitment to increasing shareholder value by reducing the number of outstanding shares.
Risk Assessment
Risk Level: low — The filing is a routine update on a share buy-back program, which is a common corporate action and does not introduce new material risks.
Key Numbers
- DKK 230.0M — Share Buy-back Cost (Total amount spent by Genmab on repurchasing shares.)
- 1.0M — Shares Repurchased (Number of Genmab shares bought back as part of the program.)
Key Players & Entities
- Genmab A/S (company) — Filer of the report and subject of the share buy-back
- DKK 230,000,000 (dollar_amount) — Total cost of shares purchased in the buy-back program
- 1,000,000 (dollar_amount) — Number of shares repurchased by Genmab
- DKK 230.00 (dollar_amount) — Average price per share paid in the buy-back
- June 16, 2025 (date) — Date of the company announcement regarding share buy-back transactions
FAQ
What was the total amount Genmab spent on its share buy-back program on June 16, 2025?
Genmab A/S spent DKK 230,000,000 on its share buy-back program on June 16, 2025.
How many shares did Genmab repurchase as part of its program on June 16, 2025?
Genmab repurchased 1,000,000 shares on June 16, 2025.
What was the average price per share paid by Genmab in its June 16, 2025 buy-back?
The average price per share paid by Genmab was DKK 230.00.
What is the purpose of the transactions announced on June 16, 2025?
The transactions are related to Genmab's share buy-back program, aimed at returning capital to shareholders.
Under which form is this report filed with the SEC?
This report is filed under Form 6-K.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 16, 2025 regarding GENMAB A/S (GNMSF).